A Phase 1, Open-Label, Multicenter Study Evaluating MK-1084 As Monotherapy and in Combination with Other Therapies in Patients with KRAS G12C Mutant Advanced Solid Tumors.

Iwona A. Lugowska,Carlos Rojas,Anastasios Stathis, Susanne Weindler,Abhijit Pal,Eduardo Castanon Alvarez,Jacek Mackiewicz,Marcelo Garrido,Mehmet Ali Nahit Sendur,Nehal J. Lakhani,Sophia Frentzas,Rafal Dziadziuszko,Adrian G. Sacher,Kazushige Wakuda,Terufumi Kato,Ruth Perets,Omar Orlando Castillo Fernandez,Thomas Jemielita, Yewon Choi,Rosalyn A. Juergens

Journal of Clinical Oncology（2024）

Cited 1|Views5

Key words

613-225-2575-3984,283-324,261-566-9263,298-4767-7539,298-145-222-184-4809-5347,283-197-481,283-237-255-11316,126,242,239,193,54,38092-25821,38092-20072

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined